South Africa tracks HIV injection uptake through digital health system

South Africa’s roll-out of lenacapavir (LEN), a twice-yearly HIV prevention injection, began in June, but measuring its success goes beyond counting initial doses. The true measure lies in whether patients return every six months for follow-up injections—and whether clinics can coordinate care nationwide. By mid-October, nearly 79,000 people had received their first dose, but the first wave of repeat injections is due in December. Without reliable tracking, health officials risk managing the program blindly, unable to pinpoint where uptake slows, which groups are missed, or where stock shortages emerge. That’s where SyNCH, a digital health platform, plays a critical role.
How a digital system tracks patients across clinics
SyNCH, or Synchronised National Communication in Health, links 360 public clinics nationwide—excluding the Western Cape, which operates its own separate system. Developed by the Health Systems Trust (HST) and ASG Technologies in collaboration with the national health department, the platform was originally created to manage chronic medication pickups. It has since been adapted for HIV prevention, covering both daily pills and LEN.
When a patient receives LEN, their visit is logged electronically. If they later visit another SyNCH-connected clinic, staff can access their full history, including the date of their last dose. This portability is essential in a country where people frequently move between towns or provinces for work, education, or family reasons.
The Western Cape remains the only province not integrated with SyNCH. Its independent electronic patient-record system does not sync with the national platform, leaving LEN users there disconnected from the rest of the country’s data. While South Africa still lacks a unified electronic health record, SyNCH demonstrates what’s achievable when clinics share patient information across regions.
A dashboard that reveals gaps in real time
The system does more than track individual patients. Clinic data feeds into a LEN dashboard, providing officials with live updates on uptake by age, gender, and location, broken down to the clinic level. This level of detail uncovers disparities that national averages would miss. For example, officials might observe that young adults in one district are adopting LEN widely, while clinics in another region struggle to engage them.
Related Post: South Africa’s HIV Prevention Injection Lags Adoption
Monitoring return visits is particularly vital. LEN’s six-month protection only works if patients return on schedule. SyNCH’s patient-level records allow the health department to track retention rates beyond simple injection counts. If large numbers fail to return after their first dose, the program’s effectiveness will diminish, no matter how many initially enrolled.
Stock management is another key function. Demand surges can quickly outstrip supply, leaving clinics without medication when patients return. SyNCH’s real-time data helps officials spot shortages early, enabling them to redistribute stock before gaps disrupt prevention efforts. For a medication requiring precise timing, this capability is indispensable.
The dashboard itself is not the innovation; it’s the underlying infrastructure that matters. SyNCH was not built specifically for LEN; it was repurposed from existing systems designed for chronic disease management. This adaptability highlights a broader issue: South Africa’s health programs often launch with ambitious goals, but sustaining them depends on tracking usage, identifying gaps, and ensuring clinics can meet demand.
Where the data exposes disparities, and what it reveals
The dashboard’s detailed breakdown highlights regional and demographic differences that national averages overlook. In Limpopo, urban clinics in Polokwane show higher LEN uptake among women aged 25–34, while rural facilities in the Capricorn District struggle to engage men in the same age group.
Stock management remains a persistent challenge. By late November, SyNCH alerts identified emerging shortages in three provinces: North West, where demand exceeded deliveries by 15%; the Eastern Cape, where clinics in the Buffalo City metro faced low stock; and Mpumalanga, where a single facility in Witbank turned away 47 patients due to stockouts.